IL306060A - Blocking oligonucleotides for selective depletion of unwanted fragments from amplified libraries - Google Patents

Blocking oligonucleotides for selective depletion of unwanted fragments from amplified libraries

Info

Publication number
IL306060A
IL306060A IL306060A IL30606023A IL306060A IL 306060 A IL306060 A IL 306060A IL 306060 A IL306060 A IL 306060A IL 30606023 A IL30606023 A IL 30606023A IL 306060 A IL306060 A IL 306060A
Authority
IL
Israel
Prior art keywords
blocking oligonucleotides
selective depletion
amplified libraries
desirable fragments
fragments
Prior art date
Application number
IL306060A
Other languages
English (en)
Hebrew (he)
Inventor
Colin Brown
Sarah SHULTZABERGER
Stephen M Gross
Angelica Barr
Samantha Snow
Original Assignee
Illumina Inc
Colin Brown
Sarah SHULTZABERGER
Stephen M Gross
Angelica Barr
Samantha Snow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc, Colin Brown, Sarah SHULTZABERGER, Stephen M Gross, Angelica Barr, Samantha Snow filed Critical Illumina Inc
Publication of IL306060A publication Critical patent/IL306060A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/113—Modifications characterised by incorporating modified backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/117—Modifications characterised by incorporating modified base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/186—Modifications characterised by incorporating a non-extendable or blocking moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/163—Reactions characterised by the reaction format or use of a specific feature the purpose or use of blocking probe

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL306060A 2021-03-31 2022-03-30 Blocking oligonucleotides for selective depletion of unwanted fragments from amplified libraries IL306060A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163169185P 2021-03-31 2021-03-31
PCT/US2022/022663 WO2022212589A1 (en) 2021-03-31 2022-03-30 Blocking oligonucleotides for the selective depletion of non-desirable fragments from amplified libraries

Publications (1)

Publication Number Publication Date
IL306060A true IL306060A (en) 2023-11-01

Family

ID=81346581

Family Applications (1)

Application Number Title Priority Date Filing Date
IL306060A IL306060A (en) 2021-03-31 2022-03-30 Blocking oligonucleotides for selective depletion of unwanted fragments from amplified libraries

Country Status (11)

Country Link
US (1) US20240191288A1 (cg-RX-API-DMAC7.html)
EP (1) EP4314335A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024512463A (cg-RX-API-DMAC7.html)
KR (1) KR20230163386A (cg-RX-API-DMAC7.html)
CN (1) CN117098855A (cg-RX-API-DMAC7.html)
AU (1) AU2022252302A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023019999A2 (cg-RX-API-DMAC7.html)
CA (1) CA3213037A1 (cg-RX-API-DMAC7.html)
IL (1) IL306060A (cg-RX-API-DMAC7.html)
MX (1) MX2023011523A (cg-RX-API-DMAC7.html)
WO (1) WO2022212589A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024137316A1 (en) * 2022-12-23 2024-06-27 Foundation Medicine, Inc. Oligonucleotides and methods for capturing single-stranded templates and/or templates with 3' overhangs
WO2024220771A1 (en) * 2023-04-21 2024-10-24 Ohio State Innovation Foundation Rapid enzyme-free release of single-stranded dna from unmodified dsdna templates
WO2025244841A1 (en) 2024-05-23 2025-11-27 Illumina, Inc. Methods and systems for quantifying targeted enrichment efficiency
CN120060439B (zh) * 2025-02-27 2026-03-10 江苏硕世生物科技股份有限公司 一种基于封闭引物去人源核酸的测序文库构建方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5677170A (en) 1994-03-02 1997-10-14 The Johns Hopkins University In vitro transposition of artificial transposons
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5962271A (en) 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
US5849497A (en) * 1997-04-03 1998-12-15 The Research Foundation Of State University Of New York Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker
US6391592B1 (en) * 2000-12-14 2002-05-21 Affymetrix, Inc. Blocker-aided target amplification of nucleic acids
JP5073967B2 (ja) 2006-05-30 2012-11-14 株式会社日立製作所 単一細胞の遺伝子発現定量方法
CA2877094A1 (en) * 2012-06-18 2013-12-27 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US20140274729A1 (en) * 2013-03-15 2014-09-18 Nugen Technologies, Inc. Methods, compositions and kits for generation of stranded rna or dna libraries
WO2017142989A1 (en) * 2016-02-17 2017-08-24 Admera Health LLC Nucleic acid preparation and analysis
US11319583B2 (en) * 2017-02-01 2022-05-03 Becton, Dickinson And Company Selective amplification using blocking oligonucleotides
SG11201910070PA (en) * 2017-05-08 2019-11-28 Illumina Inc Universal short adapters for indexing of polynucleotide samples
SG11202100713VA (en) * 2018-09-25 2021-04-29 Qiagen Sciences Llc Depleting unwanted rna species

Also Published As

Publication number Publication date
BR112023019999A2 (pt) 2023-11-14
MX2023011523A (es) 2023-10-06
KR20230163386A (ko) 2023-11-30
AU2022252302A1 (en) 2023-09-14
CN117098855A (zh) 2023-11-21
JP2024512463A (ja) 2024-03-19
CA3213037A1 (en) 2022-10-06
WO2022212589A1 (en) 2022-10-06
US20240191288A1 (en) 2024-06-13
EP4314335A1 (en) 2024-02-07

Similar Documents

Publication Publication Date Title
ES3065771T3 (en) Substituted oxoisoindoline compounds for the treatment of cancer
IL278086A (en) PSCK9 targeting oligonucleotides for the treatment of hypercholesterolemia and related diseases
SG11202103317XA (en) Combinatorial cancer immunotherapy
EP3781564A4 (en) Compounds for the treatment of cancer
IL316870A (en) Compounds for targeted unloading of SMARCA2
MX2023011523A (es) Bloqueo de oligonucleotidos para el agotamiento selectivo de fragmentos no deseables a partir de genotecas amplificadas.
SG11202010423VA (en) COMBINED INHIBITION OF PD-1/PD-L1, TGFß AND DNA-PK FOR THE TREATMENT OF CANCER
SG11202002060XA (en) Compounds, compositions and methods for treating or preventing her-driven drug-resistant cancers
WO2017001926A8 (en) Therapeutic inhibitory compounds
WO2017001936A3 (en) Therapeutic inhibitory compounds
IL285807A (en) Immunotherapy for cancer treatment
IL290177A (en) History of 4,2,1-oxadiazol-5-one for cancer therapy
IL286872A (en) Antisense oligonucleotides for the treatment of usher syndrome
WO2012051207A3 (en) FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
SG11202104119PA (en) Liner assembly, reaction chamber and semiconductor processing apparatus
IL287901A (en) A process for making clc-1 chloride channel inhibitors
SMT202400013T1 (it) Cellule t car contro bcma per il trattamento di mieloma multiplo
IL304751A (en) A process for the detritylation of oligonucleotides
SG11202000515TA (en) Faraday shield and reaction chamber
IL289201A (en) Compounds for the treatment of cancer
GB201909468D0 (en) Compounds for treating cancer
IL283885A (en) cxcr7 inhibitors for cancer therapy
EP3794911A4 (en) DISCHARGE CHAMBERS AND IONIZATION DEVICES, METHODS AND SYSTEMS USING THEM
HK40106194A (en) Blocking oligonucleotides for the selective depletion of non-desirable fragments from amplified libraries
EP4019495A4 (en) NEW COMPOUND HAVING CANCER METASTASIS INHIBITING ACTIVITY, METHOD FOR THE PREPARATION, AND PHARMACEUTICAL COMPOSITION FOR THE INHIBITION OF CANCER METASTASIS AND THEIR PROLIFERATION OR FOR THE TREATMENT OF COLORECTAL CANCER, COMPRISING THE SAID COMPOUND